Valuation: American Shared Hospital Services

Market Cap 9.47M 8.33M 7.74M 7.12M 13.35M 917M 13.59M 92.56M 36.1M 447M 35.57M 34.8M 1.55B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 9.47M 8.33M 7.74M 7.12M 13.35M 917M 13.59M 92.56M 36.1M 447M 35.57M 34.8M 1.55B EV / Sales 2026 *
0.32x
EV / Sales 2027 * -
Free-Float
65.29%
Yield 2026 *
-
Yield 2027 * -
1 day+0.35%
1 week-1.70%
Current month-8.54%
1 month-1.70%
3 months+8.24%
6 months-31.19%
Current year-31.52%
1 week 1.4
Extreme 1.4
1.48
1 month 1.37
Extreme 1.37
1.74
Current year 1.25
Extreme 1.25
2.39
1 year 1.25
Extreme 1.25
3.11
3 years 1.25
Extreme 1.25
4.6
5 years 1.25
Extreme 1.25
4.6
10 years 0
Extreme 0
5.04
Manager TitleAgeSince
Chief Executive Officer 72 2026-04-26
Director of Finance/CFO 42 2026-07-06
Sales & Marketing - 2023-01-31
Director TitleAgeSince
Director/Board Member 74 2015-12-31
Chairman 68 2023-03-06
Director/Board Member 69 2021-12-27
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Other

Chief Financial Officer

9,634 0.1454%
3/26/26 Other

Chairman

100,000 1.5225%
6/26/25 Other

Chairman

110,000 1.7134%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-1.70%-43.33%-47.07% 9.47M
+10.74%+7.57%+43.53%+156.08% 64.84B
+6.25%+4.70%+15.19%+6.27% 29.67B
+7.95%+6.53%+16.32%+20.14% 5.04B
+11.76%+13.59% - - 4.38B
+0.47%-4.72%+19.10%+91.86% 3.85B
+1.56%-1.93%+3.16%+28.18% 2.88B
+0.83%+9.46%-57.96%-21.10% 1.4B
+1.49%+2.70%+39.09%+385.18% 1.4B
-0.39%-1.55%+51.49%+117.71% 1.01B
Average +4.09%-1.29%+9.62%+81.92% 11.45B
Weighted average by Cap. +8.62%-0.95%+31.45%+104.19%

Financials

2026 *2027 *
Net sales 29.95M 26.34M 24.47M 22.51M 42.21M 2.9B 42.96M 293M 114M 1.41B 112M 110M 4.91B -
Net income - -
Net Debt - -
Logo American Shared Hospital Services
American Shared Hospital Services is a provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). It can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The Company provides radiation therapy services both domestically and internationally.
Employees
83
Date Price Change Volume
26-07-23 US$1.445 +1.05% 4,783
26-07-22 US$1.430 -1.52% 3,608
26-07-21 US$1.452 -1.22% 14,469
26-07-20 US$1.470 +2.80% 14,330
26-07-17 US$1.430 -2.72% 7,506

Quarterly revenue - Rate of surprise